71 related articles for article (PubMed ID: 3117718)
21. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
22. Orally administered rapamycin, dacarbazine or both for treatment of human melanoma evaluated in severe combined immunodeficiency mice.
Thallinger C; Skorjanec S; Soleiman A; Tzaneva S; Griss J; Rous W; Poeppl W; Weinlich G; Karimian-Teherani D; Joukhadar C
Pharmacology; 2008; 82(3):233-8. PubMed ID: 18810248
[TBL] [Abstract][Full Text] [Related]
23. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine.
Melichar B; Voboril Z; Lojík M; Krajina A
Hepatogastroenterology; 2009; 56(93):1157-62. PubMed ID: 19760961
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
[TBL] [Abstract][Full Text] [Related]
25. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
26. Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate.
Ogawa Y; Kawamura T; Furuhashi M; Tsukamoto K; Shimada S
J Dermatol Sci; 2008 Sep; 51(3):190-9. PubMed ID: 18485676
[TBL] [Abstract][Full Text] [Related]
27. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
Pyrhönen S; Hahka-Kemppinen M; Muhonen T; Nikkanen V; Eskelin S; Summanen P; Tarkkanen A; Kivelä T
Cancer; 2002 Dec; 95(11):2366-72. PubMed ID: 12436444
[TBL] [Abstract][Full Text] [Related]
28. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
Rudolf Z; Strojan P
Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
[TBL] [Abstract][Full Text] [Related]
29. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
[TBL] [Abstract][Full Text] [Related]
30. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma].
Tessier MH; Mansat E; Legoux B; Litoux P; Dreno B
Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103
[TBL] [Abstract][Full Text] [Related]
31. Ocular metastasis of in vivo and in vitro derived syngeneic murine melanoma.
Harning R; Szalay J
Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1599-604. PubMed ID: 3623843
[TBL] [Abstract][Full Text] [Related]
32. A treatment for metastasis of murine ocular melanoma.
Harning R; Szalay J
Invest Ophthalmol Vis Sci; 1988 Oct; 29(10):1505-10. PubMed ID: 3170123
[TBL] [Abstract][Full Text] [Related]
33. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
34. Suppression of UV carcinogenesis by difluoromethylornithine in nucleotide excision repair-deficient Xpa knockout mice.
Rebel H; van Steeg H; Beems RB; Schouten R; de Gruijl FR; Terleth C
Cancer Res; 2002 Mar; 62(5):1338-42. PubMed ID: 11888902
[TBL] [Abstract][Full Text] [Related]
35. Ineffectiveness of adjuvant chemotherapy using DTIC and cyclophosphamide in patients with resectable metastatic melanoma.
Balch CM; Murray D; Presant C; Bartolucci AA
Surgery; 1984 Apr; 95(4):454-9. PubMed ID: 6369594
[TBL] [Abstract][Full Text] [Related]
36. Enucleation-induced metastasis of intraocular melanomas in mice.
Niederkorn JY
Ophthalmology; 1984 Jun; 91(6):692-700. PubMed ID: 6462628
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effect of immune ribonucleic acid in an adjuvant setting: prevention of pulmonary metastases after primary melanoma resection.
Wang BS; Steele G; Mannick JA
Surg Forum; 1978; 29():124-6. PubMed ID: 95722
[No Abstract] [Full Text] [Related]
38. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model.
Wack C; Becker JC; Bröcker EB; Lutz WK; Fischer WH
Melanoma Res; 2001 Jun; 11(3):247-53. PubMed ID: 11468513
[TBL] [Abstract][Full Text] [Related]
39. Porcine splenic peptides (Polyerga) decrease the number of experimental lung metastases in mice.
Jurin M; Zarković N; Ilić Z; Borović S; Hartleb M
Clin Exp Metastasis; 1996 Jan; 14(1):55-60. PubMed ID: 8521617
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of antitumor activity of alpha-difluoromethyl ornithine by the immunomodulating peptide tuftsin.
Sunkara PS; Prakash NJ; Nishioka K
Ann N Y Acad Sci; 1983; 419():268-72. PubMed ID: 6424536
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
